· Form D filing · Baseline
Reported sold as filed: $1,999,999 · Offering amount as filed: $1,999,999
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗On its website, the company describes its work as “OncoSmart is our AI-powered, digital transformation platform that optimizes and simplifies the complexities of community cancer clinic scheduling and nurse assignment operations. OncoSmart integrates with…”.
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.
· Form D filing · Baseline
Reported sold as filed: $1,999,999 · Offering amount as filed: $1,999,999
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗